| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |